Clinical Challenges

Aromatase Inhibitor-Associated Bone Loss

Jane Bryce

Martina Bauer

Peyman Hadji

aromatase inhibitors, bone mineral density
ONF 2011, 38(3), 273-276. DOI: 10.1188/11.ONF.273-276
Members Only
Not a current ONS member or journal subscriber?

Become a Member

Explore the benefits of membership.
Join ONS or Renew Membership

Purchase This Article

Receive a PDF to download and print.